STRATA Skin Sciences, Inc.

SSKN OTC CIK: 0001051514

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 5 WALNUT GROVE DRIVE, HORSHAM, PA, 19044
Mailing Address 5 WALNUT GROVE DRIVE, HORSHAM, PA, 19044
Phone 215-619-3200
Fiscal Year End 1231
EIN 133986004

Financial Overview

FY2025

$39.38M
Total Assets
$30.05M
Total Liabilities

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 26, 2026 View on SEC
8-K Current report of material events February 11, 2026 View on SEC
8-K Current report of material events December 17, 2025 View on SEC
8-K Current report of material events December 10, 2025 View on SEC
4 Insider stock transaction report November 18, 2025 View on SEC
10-Q Quarterly financial report November 14, 2025 View on SEC
8-K Current report of material events November 13, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 7, 2025 View on SEC
DEF 14A Definitive proxy statement October 30, 2025 View on SEC
8-K Current report of material events October 16, 2025 View on SEC

Annual Reports

10-K March 26, 2026
  • Proven 'printer' business model generates 80% of revenue through recurring treatment fees.
  • Strategic shift to direct-sales model in international markets to improve profit margins.
View Analysis

Material Events

8-K Financial Distress February 11, 2026
High Impact
  • Strategic move to 'go dark' to cut significant public company costs.
  • Expected annual savings of millions of dollars, reducing cash burn.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.